Internal Medicine, Clinical Cardiatric Electrophysiology · Olathe, KS
NPI
1336235035
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
20805 W 151st St, Building 2, Suite 400
Olathe, KS, 66061
Phone (913) 780-4900
Groups this clinician bills Medicare through
Medicare paid, 2024
$420K
7,317 services
Medicare patients, 2024
1,414
Average age 78
Drug cost, 2024
$1.8M
7,297 prescriptions
Company payments, 2025
$3,151
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ravi K Yarlagadda was code 93296 (external electrocardiographic monitoring), 1,750 times for 766 patients. In total Ravi K Yarlagadda billed 7,317 services in 69 codes, and Medicare paid $420K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93296 External Electrocardiographic Monitoring | Office | 1,750 | 766 | $14.03 | $25K |
| 93294 External Electrocardiographic Monitoring | Office | 1,270 | 548 | $20.32 | $26K |
| 93297 External Electrocardiographic Monitoring | Office | 1,087 | 212 | $41.93 | $46K |
| 93295 External Electrocardiographic Monitoring | Office | 502 | 227 | $24.87 | $12K |
| 99214 Office E&M - Established | Office | 476 | 425 | $87.51 | $42K |
| 93298 External Electrocardiographic Monitoring | Office | 406 | 81 | $61.99 | $25K |
| 93000 Electrocardiogram | Office | 282 | 253 | $9.84 | $2,774 |
| 99232 Hospital E&M - Subsequent | Facility | 242 | 146 | $58.47 | $14K |
| 99204 Office E&M - New | Office | 182 | 182 | $116.63 | $21K |
| 99223 Hospital E&M - Initial | Facility | 119 | 110 | $127.99 | $15K |
| 93280 External Electrocardiographic Monitoring | Office | 88 | 82 | $56.13 | $4,940 |
| 99214 Office E&M - Established | Facility | 85 | 82 | $71.56 | $6,083 |
| 99222 Hospital E&M - Initial | Facility | 64 | 63 | $96.64 | $6,185 |
| 33208 Pacemaker Insertion or Repair | Facility | 51 | 51 | $356.80 | $18K |
| 93623 Comprehensive Electrophysiologic Evaluation | Facility | 44 | 43 | $47.77 | $2,102 |
By year: 2022 $523K for 11,099 services; 2023 $352K for 6,525 services; 2024 $420K for 7,317 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ravi K Yarlagadda prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,478 prescriptions and refills. In total Ravi K Yarlagadda wrote 7,297 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,478 | 2,294 | 352 | $1.3M |
| Dofetilide Generic | 824 | 1,428 | 210 | $95K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 558 | 1,055 | 161 | $10K |
| Metoprolol Succinate Generic | 468 | 1,056 | 154 | $5,495 |
| Sotalol Sotalol Hcl | 463 | 959 | 127 | $7,333 |
| Flecainide Acetate Generic | 435 | 909 | 134 | $16K |
| Xarelto Rivaroxaban | 337 | 562 | 80 | $309K |
| Amiodarone Hcl Generic | 217 | 398 | 80 | $3,215 |
| Warfarin Sodium Generic | 209 | 405 | 55 | $1,024 |
| Carvedilol Generic | 170 | 383 | 56 | $1,287 |
| Lisinopril Generic | 152 | 397 | 55 | $793 |
| Losartan Potassium Generic | 142 | 345 | 58 | $1,007 |
| Furosemide Generic | 142 | 283 | 47 | $487 |
| Metoprolol Tartrate Generic | 139 | 310 | 44 | $627 |
| Potassium Chloride Generic | 138 | 292 | 50 | $2,468 |
Brand drugs: 1,948 claims; generic drugs: 5,349 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ravi K Yarlagadda $3,151 ($3,151 in general payments such as food, travel and fees) from 12 companies. The largest payer was Biosense Webster, Inc. with $1,550.
| Company | Payments | Amount |
|---|---|---|
| Biosense Webster, Inc. JNJ | 148 | $1,550 |
| Medtronic, Inc. MDT | 43 | $849 |
| Boston Scientific Corporation BSX | 22 | $469 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $88.74 |
| Abbott Laboratories ABT | 2 | $46.28 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $27.34 |
| Dexcom, Inc. DXCM | 1 | $26.6 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24.23 |
| Cardiva Medical, Inc. | 1 | $21.45 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $17.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.